Literature DB >> 25732995

Diet History Is a Reliable Predictor of Suboptimal Docosahexaenoic Acid Levels in Adult Patients with Phenylketonuria.

T Bosdet1, J Branov, C Selvage, M Yousefi, S Sirrs.   

Abstract

BACKGROUND: Omega-3 long-chain polyunsaturated fatty acids (n3LCPUFA) levels are reduced in phenylketonuria (PKU). Recent care guidelines recommend essential fatty acid status is monitored in patients with PKU but access to such testing is limited. We hypothesized that information obtained on diet history would identify PKU adults with suboptimal levels of n3LCPUFA.
METHODS: A 12-month single site prospective study was completed including 35 adults (age 18-46) attending a clinic for adults with inborn errors of metabolism. Levels of n3LCPUFA were correlated with estimated intake using a published food frequency questionnaire. n3LCPUFA levels were tested at a commercial laboratory and values > one SD below the laboratory mean value were considered suboptimal.
RESULTS: Mean levels of docosahexaenoic acid (DHA) were lower and levels of eicosapentaenoic acid (EPA) and alpha-linoleic acid (ALA) higher in subjects with PKU than in laboratory controls. n3LCPUFA levels correlated with estimated intake (p <0.002). Diet history had a positive predictive value of 93% and negative predictive value of 90% to identify subjects with suboptimal n3LCPUFA levels.
CONCLUSIONS: Diet history is sufficient to predict adult subjects who may have low DHA levels and can be used to target testing or supplementation to those at risk. DHA levels are low despite high levels of ALA suggesting that supplementation, if indicated, should be with preformed DHA rather than with its precursors.

Entities:  

Year:  2015        PMID: 25732995      PMCID: PMC4470952          DOI: 10.1007/8904_2014_399

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  17 in total

1.  [Neurological, neuropsychological, and ophthalmological evolution after one year of docosahexaenoic acid supplementation in phenylketonuric patients].

Authors:  Alfonso P Gutiérrez-Mata; M Antonia Vilaseca; Antoni Capdevila-Cirera; Mariona Vidal-Oller; Itziar Alonso-Colmenero; Roser Colomé; Anna López-Sala; Nilo Lambruschini-Ferri; Alejandra Gutiérrez; Rosa Gassió; Rafael Artuch; Jaume Campistol
Journal:  Rev Neurol       Date:  2012-08-16       Impact factor: 0.870

2.  Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet.

Authors:  K Moseley; R Koch; A B Moser
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

Review 3.  Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis.

Authors:  Szimonetta Lohner; Katalin Fekete; Tamás Decsi
Journal:  Nutr Res       Date:  2013-06-10       Impact factor: 3.315

4.  Fish oil supplementation improves visual evoked potentials in children with phenylketonuria.

Authors:  S Beblo; H Reinhardt; A C Muntau; W Mueller-Felber; A A Roscher; B Koletzko
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

5.  Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children negatively correlate with dietary compliance.

Authors:  C Agostoni; F Marangoni; E Riva; M Giovannini; C Galli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1997-03       Impact factor: 4.006

6.  A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria.

Authors:  Sarah H L Yi; Julie A Kable; Marian L Evatt; Rani H Singh
Journal:  J Inherit Metab Dis       Date:  2011-02-09       Impact factor: 4.982

7.  Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake.

Authors:  A P Pöge; K Bäumann; E Müller; M Leichsenring; H Schmidt; H J Bremer
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 8.  Omega-3 LC-PUFA supply and neurological outcomes in children with phenylketonuria (PKU).

Authors:  Berthold Koletzko; Skadi Beblo; Hans Demmelmair; Fabienne L Hanebutt
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-03       Impact factor: 2.839

9.  Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria.

Authors:  Skadi Beblo; Hannes Reinhardt; Hans Demmelmair; Ania C Muntau; Berthold Koletzko
Journal:  J Pediatr       Date:  2007-05       Impact factor: 4.406

Review 10.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

View more
  1 in total

1.  Dental Status and Periodontal Health of Patients with Phenylketonuria in Latvia.

Authors:  Iveta Ābola; Dārta Elizabete Emuliņa; Ingus Skadiņš; Anda Brinkmane; Linda Gailīte; Madara Auzenbaha
Journal:  Acta Stomatol Croat       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.